This inventor holds 1 USPTO granted patent. Top assignee: Oxford Finance LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 Years Active: 2026
Title: Mark Pogson: Innovator in Targeted Immunotherapies
Introduction
Mark Pogson is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunotherapy, particularly with his innovative work on targeted therapies.
Latest Patents
Mark Pogson holds a patent for "CD33 Targeted Immunotherapies." This patent represents a crucial advancement in the treatment of certain diseases, showcasing his commitment to improving healthcare through innovation. He has 1 patent to his name.
Career Highlights
Mark Pogson is currently employed at Oxford Finance LLC, where he continues to develop and refine his ideas in the realm of immunotherapy. His work is characterized by a strong focus on practical applications that can lead to better patient outcomes.
Collaborations
Throughout his career, Mark has collaborated with talented individuals such as Jordan Jarjour and Andrew Hollands. These partnerships have allowed him to enhance his research and expand the impact of his innovations.
Conclusion
Mark Pogson is a dedicated inventor whose work in targeted immunotherapies is paving the way for advancements in medical treatments. His contributions are vital to the ongoing evolution of healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile